Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Single-cell characterization of the immune heterogeneity of pulmonary hypertension identifies novel targets for immunotherapy

Fig. 2

Comprehensive single-cell transcriptomic analysis reveals T cell heterogeneity and functional dynamics in PAH. A UMAP plot showing the clustering and annotation of T cell subsets in PAH and healthy control samples, including CD8 + Effector, CL_CD4 + CCR6 + , Activated T, CD4 + Naïve, CD8 + Naïve, and NK cells. Each cluster represents a distinct functional subset, highlighting the heterogeneity within the T cell population. B and C Bar and pie charts displaying the proportions and counts of different T cell subsets in the PAH group and healthy controls. Activated T cells and CD8 + Effector T cells show significant increases in the PAH group, while Naïve T cells decrease, indicating enhanced immune activation in PAH. D UMAP plots displaying T cell distribution across different disease states (Con, IPAH, PHHF, SSc-PH), accompanied by line charts showing the proportion of T cell subsets in each condition. Disease-specific shifts in T cell composition are observed, with notable changes in IPAH and SSc-PH. E Monocle2 and Monocle3 pseudotime trajectories of T cell subsets, showing dynamic transitions from Naïve T cells to Activated T cells and CD8 + Effector T cells. Violin plots illustrate gene expression trends along the pseudotime axis, reflecting the functional evolution of T cells in PAH. F Heatmap of differentially expressed genes across T cell subsets, with enriched pathways annotated, including leukocyte adhesion, inflammatory response, and immune activation. Key pathways suggest that T cells contribute to inflammation, tissue remodeling, and disease progression in PAH. G Heatmap of TF activity across T cell subsets, highlighting TFs with altered activity in PAH, such as NFATC1, HIF1A, BATF, STAT1, and FOXP3. These TFs regulate immune activation, metabolic adaptation, and inflammatory processes

Back to article page